Abstract
Purpose
To provide a rationale for continuation of efforts to improve the outcome of Assisted Reproductive Technology outcomes, thereby increasing the likelihood of the live birth of healthy neonates.
Methods
Description of rationale and a framework leading to improvement in Assisted Reproductive Technology outcomes.
Results
The opportunity for improvement in the success rate for Assisted Reproductive Technology outcome is predicated on selection of the highest quality embryo(s) for transfer. However, such approaches must be balanced by a limit to the number of embryos transferred so as to reduce the risk for multiple births and particularly higher order multiple gestations. Blastocyst transfer offers one such successful approach, but is confounded by suggestions of an increased risk of both pregnancy complications and epigenetic disorders.
Conclusion
There is a need for development of approaches which, individually or in combination, may assist in the early detection of embryos destined to develop into blastocysts.
Similar content being viewed by others
References
Bergh T, Ericson A, Hillensjo T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilization in Sweden 1982–95: a retrospective cohort study. Lancet. 1999;354(9190):1579–85. doi:10.1016/S0140-6738(99)04345-7.
Blake DA, Farquhar CM, Johnson N, Proctor M. Clevage stage versus blastocyst embryo stage embryo transfer in assisted conception. Cochrane Database System Reviews 2007;CD002118, doi:10.1002/14651858.CD002118.pub3
Blennborn M, Nilsson S, Hillervik C, Hellberg D. The couple’s decision-making in IVF: one or two embryos at a transfer? Hum Reprod. 2005;20:292–7. doi:10.1093/humrep/deh785.
Botting BJ, Davies IM, Macfarlane AJ. Recent trends in the incidence of multiple births and associated mortality. Arch Dis Child. 1987;62:941–50. PMICD: PMC1778571.
Callahan TL, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley Jr WF. The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to the incidence. N Engl J Med. 1994;331(4):244–9.
Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE, Delemarre-van de Waal HA. Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab. 2008;93(5):1682–8. doi:10.1210/jc.2007-2432.
Center for Disease Control 2008 Assisted Reproductive Technology Report, “http://www.cdc.gov/art/ART2008/”
Collins MS, Bleyl JA. Seventy-one quadruplet pregnancies: management and outcome. Am J Obstet Gynecol. 1990;162(6):1384–9.
Crump C, Sundquist K, Sundquist J. Gestational age at birth and mortality in young adulthood. JAMA. 2011;306(11):1233–40. doi:10.1001/jama.2011.1331.
DeMuylder X, Moutquin JM, Desfranges MF, Leduc B, Lazaro-Lopez F. Obstetrical profile of twin pregnancies: a retrospective review of 11 years (1969–1979) at Hospital Notre-Dame, Montreal, Canada. Acta Genetics Medicine Gemellol (Roma). 1982;31(3–4):149–55.
Dessolle L, Freour T, Barrier P, Darai E, Ravel C, Jean M, et al. A cycle-based model to predict blastocyst transfer cancellation. Hum Reprod. 2010;25(3):598–604. doi:10.1093/humrep/dep439.
Devine PC, Malone FD, Athanassiou A, Harvey-Wilkes K, D’Alton ME. Maternal and neonatal outcome of 100 consecutive triplet pregnancies. Am J Perinatol. 2001;18(4):225–35. doi:10.1055/s-2001-15505.
Downey J, Yingling S, McKinney M, Husami N, Jewelewicz R, Maidman J. Mood disorders, psychiatric symptoms, and distress in women presenting for infertility evaluation. Fertil Steril. 1989;52(3):425–32.
Elster AD, Bleyl JL, Craven TE. Birth weight standards for triplets under modern obstetric care in the United States, 1984–1989. Obstet Gynecol. 1991;77(3):387–93.
Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril. 1998;69:84–8. doi:10.1016/S0015-0282(97)00438-X.
Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73:1155–8. doi:10.1016/S0015-0282(00)00518-5.
Guerif F, Ale G, Giraudeau B, Poindron J, Bidault R, Gasnier O, et al. Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod. 2007;22(7):1973–81. doi:10.1093/humrep/dem100.
Guerif F, Lemseffer M, Bidault R, Gasnier O, Saussereau MH, Cadoret V, et al. Single Day 2 versus blastocyst-stage transfer: a prospective study integrating fresh and frozen embryo transfers. Hum Reprod. 2009;24:1051–8. doi:10.1093/humrep/dep018.
Jain T, Missmer SA, Hornstein MD. Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technologies in the United States. N Engl J Med. 2004;350(16):1639–45.
Jones GM, Trounson AO, Gardner DK, Kausche A, Lolatgis N, Wood C. Evolution of a culture protocol for successful blastocyst development and pregnancy. Hum Reprod. 1998;13:169–77. doi:10.1093/humrep/13.1.169.
Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Blastocyst versus cleavage stage transfer in in vitro fertilization: differences in neonatal outcome? Fertil Steril. 2010;94(5):1680–3. doi:10.1016/j.fertnstert.2009.12.027.
Kalra SK, Ratcliffe SJ, Barnhart KT, Coutifaris C. Day 3 vs. blastocyst embryo transfer: extended embryo culture is associated with an increased risk of preterm delivery. Fertil Steril. 2010;94(4):S242. doi:10.1016/j.fertnstert.2010.07.938.
Katari S, Turan N, Bibikova M, Erinie O, Chalian R, Foster M, et al. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet. 2009;18:3769–78. doi:10.1093/hmg/ddp319.
Kaufman GE, Malone FD, Harvey-Wilkes KB, Chelmow D, Penzias AS, D’Alton ME. Neonatal morbidity and mortality associated with triplet pregnancies. Obstet Gynecol. 1998;91(3):342–8.
Khosla S, Dean W, Reik W, Feil R. Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Hum Reprod Updat. 2001;7(4):419–27. doi:10.1093/humupd/7.4.419.
Kiely JL, Kleinman JC, Kiely M. Triplets and higher-order multiple births. Time trends and infant mortality. Am J Dis Child. 1992;146(7):862–8.
Leach L, Mann GE. Consequences of fetal programming for cardiovascular disease in adulthood. Microcirculation. 2011;18(4):253–5. doi:10.1111/j.1549-8719.2011.00097.x.
Leese B, Denton J. Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review. Hum Fertil. 2010;13:28–34. doi:10.3109/14647270903586364.
Levene MI, Wild J, Steer P. Higher multiple births and the modern management of infertility in Britain. The British association of perinatal medicine. Br J Obstet Gynaecol. 1992;99(7):607–13.
Lim D, Bowdin SC, Tee L, Kirby GA, Blair E, Fryer A, et al. Clinical and molecular genetic features of Beckwith-Wiedemann syndrome associated with assisted reproductive technologies. Hum Reprod. 2009;24(3):741–7. doi:10.1093/humrep/den406.
Lipitz S, Reichman B, Paret G, Modan M, Shalev J, Serr DM, et al. The improving outcome of triplet pregnancies. Am J Obstet Gynecol. 1989;161(5):1279–84. PMID: 2589451.
Lipitz S, Frenkel Y, Watts C, Ben-Fafael Z, Barkai G, Reichman B. High-order multifetal gestation—management and outcome. Obstet Gynecol. 1990;76(2):215–8.
Lucifero D, Chaillet JR, Trasler JM. Potential significance of genomic imprinting defects for reproduction and assisted reproductive technology. Hum Reprod Updat. 2004;10:3–18. doi:10.1093/humupd/dmh002.
Marek D, Langley M, Gardner DK, Confer N, Doody KM, Doody KJ. Introduction of blastocyst culture and transfer for all patients in an in vitro fertilization program. Fertil Steril. 1999;72:1035–40.
Newman RB, Hamer C, Miller MC. Outpatient triplet management: a contemporary review. Am J Obstet Gynecol. 1989;161(3):547–53.
Papanikolaou EG, D’haeseleer E, Verheyen G, Van de Velde H, Camus M, Van Steirteghem A, et al. Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. Hum Reprod. 2005;20(11):3198–203. doi:10.1093/humrep/dei217.
Papanikoleau EG, Camus M, Kolibianakis EM, VanLanduyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single Blastocyst-stage versus single Clevage-stage embryos. N Engl J Med. 2006;354:1139–46.
Pilgaard K, Færch K, Carstensen B, Poulsen P, Pisinger C, Pedersen O, et al. Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia. 2010;53:2526–30. doi:10.1007/s00125-010-1917-3.
Pudawer R. Unnatural Selection. The New York Times Magazine. 2011.
Racowsky C, Jackson KV, Cekleniak NA, Fox JH, Hornstein MD, Ginsburg ES. The number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer. Fertil Steril. 2000;73(3):558–64.
Rijnders PM, Jansen CAM. The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in-vitro fertilization or intracytopasmic sperm injection. Hum Reprod. 1998;13(10):2869–73. doi:10.1093/humrep/13.10.2869.
Scholtes MCW, Zeilmaker GH. A prospective, randomized study of embryo transfer results after 3 or 5 days of embryo culture in in vitro fertilization. Fertil Steril. 1996;65:1245–8.
Schroeder P. Infertility and the world outside. Fertil Steril. 1988;49(5):765–7.
Smith C, Wright N, Wales J, Mackenzie C, Primhak R, Eastell R, et al. Very low birth weight survivors have reduced peak bone mass and reduced insulin sensitivity. Clin Endocrinol. 2011;75(4):443–9. doi:10.1111/j.1365-2265.2011.04118.x.
Skiadas CC, Missmer SA, Benson CB, Gee RE, Racowsky C. Risk factors associated with pregnancies containing a monochorionic air following assisted reproductive technologies. Hum Reprod. 2008;23(6):1366–71. doi:10.1093/humrep/den045.
Stephen EH, Chandra A. Updated projections of infertility in the United States. Fertil Steril. 1998;70:30–4.
Tsirigotis M. Blastocyst stage transfer: pitfalls and benefits. Too soon to abandon current practice? Hum Reprod. 1998;13:3285–9. doi:10.1093/humrep/13.12.3285.
Watkins AJ, Fleming TP. Blastocyst environment and its influence on offspring cardiovascular health: the heart of the matter. J Anat. 2009;215:52–9. doi:10.1111/j.1469-7580.2008.01033.x.
Wehkalampi K, Hovi P, Dunkel L, Strang-Karlsson S, Järvenpää AL, Eriksson JG, et al. Advanced pubertal growth spurt in subjects born preterm: the Helsinki study of very low birth weight adults. J Clin Endocrinol Metab. 2011;96:525–33. doi:10.1210/jc.2010-1523.
Whiteford LM, Gonzalez L. Stigma: the hidden burden of infertility. Soc Sci Med. 1995;40(1):27–36. doi:10.1016/0277-9536(94)00124-C.
Wong CC, Loewke KE, Bossert NL, Behr B, De Jonge CJ, Baer TM, et al. Non-Invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage. Nat Biotechnol. 2010;28(10):1115–21. doi:10.1038/nbt.1686.
Acknowledgments
MPD and PC have served as a consultants to Auxogyn Inc. MC receives funding from ROI-HD-054956-A2.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule
A clinical need exist for establishment of approaches which can be utilized to assist in identification of embryos destined to develop into blastocysts.
Rights and permissions
About this article
Cite this article
Diamond, M.P., Willman, S., Chenette, P. et al. The clinical need for a method of identification of embryos destined to become a blastocyst in assisted reproductive technology cycles. J Assist Reprod Genet 29, 391–396 (2012). https://doi.org/10.1007/s10815-012-9732-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-012-9732-z